Genetic Technologies Ltd/ US37185R4065 /
2024-04-25 9:28:02 PM | Chg. - | Volume | Bid10:25:00 PM | Ask10:25:00 PM | High | Low |
---|---|---|---|---|---|---|
2.17USD | - | 500 Turnover: 878 |
2.01Bid Size: 3 | 4.46Ask Size: 1 | 2.27 | 2.17 |
GlobeNewswire
04-25
Ultragenyx to Host Conference Call for First Quarter 2024 Financial Results and Corporate Update
GlobeNewswire
04-25
Regeneron and Mammoth Biosciences Collaborate to Pursue Next-Generation CRISPR-Based Gene Editing fo...
GlobeNewswire
04-25
eyeDNA Therapeutics to Present 2-year Follow-up Phase I/II Data on its Investigational Gene Therapy ...
GlobeNewswire
04-24
23andMe to Present Preliminary Efficacy and Biomarker Data for 23ME-00610 at the 2024 American Socie...
GlobeNewswire
04-24
Rhythm Pharmaceuticals to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
GlobeNewswire
04-24
Gain Therapeutics Announces Positive Results from the Single Ascending Dose (SAD) Part of the Phase ...
GlobeNewswire
04-23
GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease Dat...
GlobeNewswire
04-23
Optimi Health and Kwantlen Polytechnic University Applied Genomics Centre Partner to Advance Mushroo...
GlobeNewswire
04-23
Prime Medicine to Present Preclinical Data Demonstrating Broad Potential of Prime Editing Technology...
GlobeNewswire
04-23
Sania Therapeutics presents latest from AAV gene therapy platform at the American Society of Gene & ...
GlobeNewswire
04-23
Century Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufactu...
GlobeNewswire
04-22
Regeneron to Highlight Advances in Genetic Medicine Research at American Society of Gene and Cell Th...
GlobeNewswire
04-22
Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the Am...
GlobeNewswire
04-22
Arbor Biotechnologies to Present Data Supporting Therapeutic Programs in PH1 and ALS, and the Discov...
GlobeNewswire
04-22
Tessera Therapeutics to Present New Data Across Preclinical Programs for its Gene Writing™ and Deliv...
GlobeNewswire
04-22
GeneFab Announces Two Presentations at the American Society of Gene & Cell Therapy (ASGCT) Annual Me...
GlobeNewswire
04-22
Revolutionary Scientists Honored for Advancements in Gene Therapy for Neuromuscular Diseases and RNA...
GlobeNewswire
04-22
Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering
GlobeNewswire
04-22
Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark Office
GlobeNewswire
04-22
Krystal Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Tre...